Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 5, 2005 - Issue 1
Submit an article Journal homepage
94
Views
39
CrossRef citations to date
0
Altmetric
Diagnostic Profile

FibroTest-FibroSURE™: towards a universal biomarker of liver fibrosis?

Thierry Poynard Groupe Hospitalier Pitié-Salpêtrière, 47–83 Boulevard de l’Hôpital, 75651 Paris Cedex 13, France. [email protected]
,
Françoise Imbert-Bismut Groupe Hospitalier Pitié-Salpêtrière, 47–83 Boulevard de l’Hôpital, 75651 Paris Cedex 13, France. [email protected]
,
Mona Munteanu Groupe Hospitalier Pitié-Salpêtrière, 47–83 Boulevard de l’Hôpital, 75651 Paris Cedex 13, France
&
Vlad Ratziu Groupe Hospitalier Pitié-Salpêtrière, 47–83 Boulevard de l’Hôpital, 75651 Paris Cedex 13, France. [email protected]
Pages 15-21 | Published online: 09 Jan 2014
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Abstract

Among the noninvasive alternatives to liver biopsy, several studies have demonstrated the predictive value and superior benefit/risk ratio to biopsy of two combinations of simple serum biochemical markers in patients infected with hepatitis B and C virus. These include FibroTest™ (BioPredictive) for the quantitative assessment of fibrosis, and ActiTest™ (BioPredictive) for the quantitative assessment of necroinflammatory activity (HCV-FibroSURE™, LabCorp). The possible causes of false negatives and positives are also better identified. These tests, which are now available in 12 countries, can facilitate the screening and management of the most frequent liver diseases.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.
Source: Wiley
MicroRNA-34a-5p inhibits liver fibrosis
Source: Wiley
Immune activation in alcoholics
Source: Wiley
Detecting liver fibrosis using a machine learning-based approach to the quantification of the heart-induced deformation in tagged MR images.
Source: Wiley
Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
Source: MDPI AG
Epidemiology, Natural History and Management
Source: Springer Science and Business Media LLC

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.